Abstract

Background:Liquid based cytology with dual biomarkers has improved sensitivity and specificity in detecting high grade cervical intraepithelial neoplasia (CIN). In low resource settings, especially in organized camps, LBC is costly and immunohistochemistry on conventional pap smears is difficult to standardize with consumption of lots of reagents. In present study, to improve the accuracy of conventional pap smears and reduce the cost of biomarker testing, we evaluated conventional cell blocks (CCBs) preparations with biomarkers to detect high-grade CIN in resource-poor organized screening programs. We also studied feasibility of using CCB as primary screening test.Material and Methods:A total of 350 participants were included in the cross-sectional evaluation of the screening tests. A conventional Papanicolaou (Pap) smear was obtained, and another sample was then collected and placed in 10% neutral buffered formalin for CB preparation. All abnormal Pap tests and CBs were stained for the biomarkers p16INK4a and Ki67. Histopathology with p16INK4a expression was considered the gold standard. Diagnostic tests were compared using MacNemar’s test and receiver operating curves were plotted.Results:The sensitivity, specificity, and diagnostic accuracy of CCB cytology, CB + p16 cytology and CB + p16Ki67 cytology for detecting CIN2+ lesions were 85.71%, 100%, 97.44%; 100%, 93.75%, 94.87%; and 85.71%, 100%, 97.44%, respectively. The Ki67 index could further categorize low grade lesions into lesions with low proliferative index and with high proliferative index (Pearson chi-square p value <0.001).Conclusion:If CB preparation is standardized, CCB cytology with biomarkers can have better diagnostic accuracy than conventional cytology, can classify low grade lesions likely to progress and can be used in field settings as primary screening test.

Highlights

  • The main aim of cervical cancer screening is to detect and treat high-grade cervical intraepithelial neoplasia (CIN) to prevent its progression into invasive cancer; a screening test should have optimal sensitivity and specificity for detecting these lesions (Arbyn et al, 2009)

  • We studied feasibility of using conventional cell blocks (CCBs) as a primary screening test to detect high-grade

  • CCB cytology has not been used as a primary cervical cancer screening test before

Read more

Summary

Introduction

The main aim of cervical cancer screening is to detect and treat high-grade cervical intraepithelial neoplasia (CIN) to prevent its progression into invasive cancer; a screening test should have optimal sensitivity and specificity for detecting these lesions (Arbyn et al, 2009). The sensitivity and specificity of conventional and liquid-based cytology tests have been reported to be 26-70% and 96-99%, respectively (Arbyn et al, 2008; Bergeron et al, 2015). Liquid based cytology with dual biomarkers has improved sensitivity and specificity in detecting high grade cervical intraepithelial neoplasia (CIN). To improve the accuracy of conventional pap smears and reduce the cost of biomarker testing, we evaluated conventional cell blocks (CCBs) preparations with biomarkers to detect high-grade CIN in resource-poor organized screening programs. We studied feasibility of using CCB as primary screening test

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call